Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A

G Francolini1, C Bellini2, V Di Cataldo3

  • 1Radiotherapy Unit, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|October 2, 2021
PubMed
Summary

Nodal stereotactic body radiotherapy (SBRT) shows promise for pelvic oligorecurrent disease after prostatectomy. This treatment offers encouraging disease-free survival and androgen deprivation therapy-free survival, with many patients eligible for repeat SBRT if needed.

Related Concept Videos